Search

everythinglearnresearchcommunity

for

Search:↓

Horizontally sectioned scalp biopsies are more reliable for diagnosing hair loss in women when three samples are taken instead of one.

COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.

Most patients with chronic hair shedding did not progress to permanent hair loss, and one showed improvement with treatment.

Topical vitamin D3 does not prevent hair loss from chemotherapy.

Diagnosing hair loss disorders needs clinical, dermoscopic, and histological differences, and checking menstrual cycle, weight changes, drug therapy, and nail changes.

Key genes regulate hair follicle phase changes in Inner Mongolia cashmere goats.

GasderminA3 is important for normal hair cycle transitions by controlling Wnt signaling.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

Hair loss in Cronkhite-Canada syndrome is reversible by treating the gut issues and doesn't need steroid treatment for the hair itself.

Finasteride may not stop severe hair loss after stopping minoxidil.

Some people with chronic hair loss may have thyroid autoimmunity.

Woman's hair loss diagnosis changed from CTE to AA; multiple biopsies important for accurate diagnosis.

Sandalore® improves hair growth and quality in people with hair loss.

Low iron levels are a significant risk factor for hair loss, while high vitamin D levels might be a response to hair loss, not a cause.

Most patients with telogen effluvium had low iron and vitamin D levels; iron supplements were commonly prescribed.

Proteoglycans are important for hair growth, and a specific treatment can help reduce hair loss.

Certain gene variations in the Vitamin D receptor may increase the risk of chronic hair loss.

CTE can distort results in hair growth trials, so exclude it carefully.

Obese mice with a leptin gene mutation have a longer resting phase in their hair cycle, which may help understand certain hair loss conditions.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Hair loss lotion with specific ingredients effectively improves hair growth and thickness safely.

Hair loss from telogen effluvium can cause mental health issues and lower life quality, needing both medical and emotional support.

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

Claudin-1 and Claudin-3 are crucial for keeping hair follicle structure and preventing a type of hair loss called telogen effluvium.

RV3466F lotion significantly reduces hair loss and improves acute telogen effluvium.

Middle-aged women with chronic telogen effluvium experience increased hair shedding but usually don't get significantly thinner hair.

The document concludes that a man's long hair may have helped diagnose his rare case of chronic hair shedding, for which no treatment is advised.

Low iron levels are not directly linked to chronic hair loss and iron supplements may not help.

Finasteride reverses early hair loss and promotes growth.

Bioluminescence imaging can track hair follicle cells and help study hair regrowth.